| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.036 | 0.5 |